- Home
- RLYB vs IRIX Comparison
RLYB vs IRIX Comparison
Compare RLYB & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- IRIX
- Stock Information
- Founded
- RLYB 2018
- IRIX 1989
- Country
- RLYB United States
- IRIX United States
- Employees
- RLYB N/A
- IRIX N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RLYB Health Care
- IRIX Health Care
- Exchange
- RLYB Nasdaq
- IRIX Nasdaq
- Market Cap
- RLYB 24.1M
- IRIX 20.2M
- IPO Year
- RLYB 2021
- IRIX 1996
- Fundamental
- Price
- RLYB $0.64
- IRIX $1.00
- Analyst Decision
- RLYB Hold
- IRIX
- Analyst Count
- RLYB 2
- IRIX 0
- Target Price
- RLYB N/A
- IRIX N/A
- AVG Volume (30 Days)
- RLYB 263.4K
- IRIX 91.1K
- Earning Date
- RLYB 11-06-2025
- IRIX 11-11-2025
- Dividend Yield
- RLYB N/A
- IRIX N/A
- EPS Growth
- RLYB N/A
- IRIX N/A
- EPS
- RLYB N/A
- IRIX N/A
- Revenue
- RLYB $674,000.00
- IRIX $50,647,000.00
- Revenue This Year
- RLYB N/A
- IRIX $9.61
- Revenue Next Year
- RLYB N/A
- IRIX N/A
- P/E Ratio
- RLYB N/A
- IRIX N/A
- Revenue Growth
- RLYB 12.71
- IRIX 4.58
- 52 Week Low
- RLYB $0.22
- IRIX $0.78
- 52 Week High
- RLYB $1.24
- IRIX $1.95
- Technical
- Relative Strength Index (RSI)
- RLYB 53.76
- IRIX 43.67
- Support Level
- RLYB $0.62
- IRIX $0.87
- Resistance Level
- RLYB $0.72
- IRIX $1.19
- Average True Range (ATR)
- RLYB 0.05
- IRIX 0.06
- MACD
- RLYB 0.00
- IRIX -0.01
- Stochastic Oscillator
- RLYB 37.50
- IRIX 34.65
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.